Warning Letter Roundup: Variety of GMP Repeat Violations Garner FDA Warnings

Significant GMP violations and repeating problems at U.S. companies across the drug supply chain lead the FDA to issue warning letters, including a lack of product testing at an Oklahoma drug manufacturer.
Source: Drug GMP Report